News / Africa

Report Outlines Challenges and Opportunities in Finding AIDS Vaccine

Multimedia

Audio
Joe DeCapua

At the 18th International AIDS Conference in Vienna, a new report outlines the challenges and opportunities facing vaccine researchers.  The report – The Road to Prevention – is called a scientific strategic plan to help end the epidemic.

The Global HIV Vaccine Enterprise – an alliance of independent organizations – issued the report Sunday.

Executive Director Alan Bernstein says, “The report is a preview of the strategic plan for the Enterprise, which is going to be released in September at the annual AIDS vaccine conference in Atlanta, Georgia.  It outlines some of the key challenges facing the field and suggests to some extent some ways forward.  If we’re going to stop this epidemic, we need to define a clear road to prevention.”

Working in combination with other prevention efforts

“There are other strategies in play.  Things like microbicides, pre-exposure prophylaxis, treatment as prevention, circumcision.  But we certainly know for other infectious diseases, from polio to HPV (Human Papillomavirus), that the best way to stop a virus and probably the cheapest is with a vaccine,” he says.

A microbicide can be a vaginal cream, gel or suppository that kills the AIDS virus.  Pre-exposure prophylaxis would use anti-retroviral drugs as a preventive measure, instead of treatment later on when the immune system starts to fail.

Alan Bernstein, Executive Director, Global HIV Vaccine Enterprise
Alan Bernstein, Executive Director, Global HIV Vaccine Enterprise

There are several major challenges to a vaccine.  One is the virus itself, which Bernstein calls “clever.”

“It has this ability to mutate and alter itself very quickly and very profoundly.  You know, flu changes, let’s say, once a season.  So we have a year to tool up to make a vaccine and it’s relatively easy actually to make a vaccine against flu.  But even then it changes once a year.  HIV changes daily even within one infected individual,” he says.

Another big challenge is money

“It’s difficult at the moment to raise money for any kind of research given the current economic situation globally, including HIV vaccine research.  But it’s very frustrating at the moment because on the one hand I think we all should be worried that this epidemic is reaching crisis proportions.  The new money for treatment that UNAIDS calls for today is not readily available.  And yet, more and more people are getting infected,” he says.

Scientists know HIV has a weakness.  But they must find a way to exploit it.

Bernstein says, “Every living thing must have an Achilles’ heel.  The virus can’t change everything about it and still be viable - still be able to grow inside ourselves.”

Scientists recently announced they had uncovered naturally occurring anti-bodies in some HIV positive people that prevent the virus from entering cells.  The finding presents an opportunity for vaccine research.  The trick now is to find a vaccine that will help anyone’s immune system produce such antibodies.

Global HIV Vaccine Enterprise report released at Vienna AIDS conference
Global HIV Vaccine Enterprise report released at Vienna AIDS conference

Another important development occurred late last year, when a clinical trial in Thailand showed that a human vaccine is possible.  The vaccine candidate cut the risk of infection among participants, but the results were not high enough to go to market.

“Trials are expensive,” he says, “They cost roughly a hundred million dollars each.  And we need to do, put simply, a lot more trials if we’re going to get a vaccine.  And I think the optimism in the field right now has given the whole field kind of a new momentum.  I wouldn’t have said this a year ago.  But I think it’s clear we’re into a new era in this field.  And I must say it’s frustrating not to have the funds to actually move through that door pretty boldly.

The head of the Global HIV Vaccine Enterprise won’t predict when an effective AIDS vaccine will be available.  Even if a promising candidate were found today, a clinical trial would take at least three years.

You May Like

EU Court Fines Poland for Hosting CIA 'Black Sites'

Ruling is first time a court has acknowledged suspects were held and tortured at the sites, under US program launched following the 9/11 terrorist attacks More

Migrant Issues Close to Home Spur Groups to Take Action

Groups placing water, food in the desert, or aiding detainees after release, have one common goal: no more deaths of migrants crossing illegally into the US More

Video At AIDS Conference, Prevention Pill Stirs Excitement

Truveda shows promise, spurring debate over access and other approaches More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Treatment for Childhood Epilepsy Heats up Medical Marijuana Debatei
X
Shelley Schlender
July 24, 2014 6:43 PM
In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video Death Toll From Israel-Gaza Conflict Surpasses 700

Gaza officials say a shelling hit a compound housing a United Nations-run school in the Gaza Strip, killing more than a dozen people, during an Israeli offensive in the area. Heavy fighting between the Israeli military and Hamas militants continued on Thursday, pushing up the death toll. So far, more than 730 Palestinians and 35 Israelis have been killed in the conflict. VOA's Scott Bobb has the latest from Jerusalem.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video Israel Targets Gaza Supply Tunnels

The Israeli military has launched a ground operation in Gaza to destroy the myriad tunnels that may have been used to smuggle weapons to Hamas. VOA's Zlatica Hoke reports that could mean more hardship for the people of Gaza, who obtain some of their essential supplies through these underground passages
Video

Video Researchers Target Low-Cost Avatar Technology

Scientists at the University of Southern California Institute for Creative Technologies say 3-dimensional representations could revolutionize social media. Elizabeth Lee has more from Los Angeles.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.

AppleAndroid